Atrial fibrillation after esophageal cancer surgery: An analysis of 207 consecutive patients

Surgery Today

Volumn 44, Issue 5, 2014, Pages 839-847

  Ojima, Toshiyasu ^a   Iwahashi, Makoto ^a   Nakamori, Mikihito ^a   Nakamura, Masaki ^a   Katsuda, Masahiro ^a   Iida, Takeshi ^a   Hayata, Keiji ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Esophageal cancer; Esophagectomy

Indexed keywords

LANDIOLOL;

ADULT; AGED; ARTICLE; CANCER SURGERY; COLON; ESOPHAGUS CANCER; ESOPHAGUS RECONSTRUCTION; ESOPHAGUS RESECTION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; SURGICAL RISK; TACHYCARDIA;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COLON; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOPLASTY; FEMALE; HEART RATE; HUMANS; ILEUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MORPHOLINES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACHYCARDIA; UREA;

EID: 84899917655     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-013-0616-3     Document Type: Article

References (33)

1. Hou JL, Gao K, Li M, Ma JY, Shi YK, Wang Y, et al. Increased N-terminal pro-brain natriuretic peptide level predicts atrial fibrillation after surgery for esophageal carcinoma. World J Gastroenterol. 2008;28:2582-5. (Pubitemid 352037751)
2. Ma JY, Wang Y, Zhao YF, Wu Z, Liu LX, Kou YL, et al. Atrial fibrillation after surgery for esophageal carcinoma: clinical and prognostic significance. World J Gastroenterol. 2006;21:449-52. (Pubitemid 43329264)
3. Amar D, Roistacher N, Burt M, Reinsel RA, Ginsberg RJ, Wilson RS. Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest. 1995;108:349-54.
4. Amar D, Burt ME, Bains MS, Leung DH. Symptomatic tachydysrhythmias after esophagectomy: incidence and outcome measures. Ann Thorac Surg. 1996;61:1506-9. (Pubitemid 26150246)
5. Ritchie AJ, Whiteside M, Tolan M, McGuigan JA. Cardiac dysrhythmia in total thoracic oesophagectomy. A prospective study. Eur J Cardiothorac Surg. 1993;7:420-2.
6. Murthy SC, Law S, Whooley BP, Alexandrou A, Chu KM, Wong J. Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg. 2003;126:1162-7. (Pubitemid 37305706)
7. Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg. 2006;243:204-11. (Pubitemid 43185439)
8. Force S. The "innocent bystander" complications following esophagectomy: atrial fibrillation, recurrent laryngeal nerve injury, chylothorax, and pulmonary complications. Semin Thorac Cardiovasc Surg. 2004;16:117-23. (Pubitemid 38937173)
9. Atkins BZ, Shah AS, Hutcheson KA, Mangum JH, Pappas TN, Harpole DH Jr, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170-6. (Pubitemid 39303829)
10. Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV. A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2010;140:45-51.
11. Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest. 2005;128:3421-7. (Pubitemid 41698673)
12. Sezai A, Minami K, Nakai T, Hata M, Yoshitake I, Wakui S, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg. 2011;141:1478-87.
13. Tisdale JE, Wroblewski HA, Kesler KA. Prophylaxis of atrial fibrillation after noncardiac thoracic surgery. Semin Thorac Cardiovasc Surg. 2010;22:310-20.
14. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg. 2004;127:779-86. (Pubitemid 38316184)
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th edn. New York: Springer; 2009.
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107-36.
17. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53. (Pubitemid 28319935)
18. Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68-74.
19. Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG9906). Int J Radiat Oncol Biol Phys. 2011; 81:684-90.
20. Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486-94.
21. Noshiro H, Iwasaki H, Kobayashi K, Uchiyama A, Miyasaka Y, Masatsugu T, et al. Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer. Surg Endosc. 2010;24:2965-73.
22. Bonavina L, Bona D, Binyom PR, Peracchia A. A laparoscopy-assisted surgical approach to esophageal carcinoma. J Surg Res. 2004;117:52-7. (Pubitemid 38317209)
23. Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, et al. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2008;393:127-33.
24. Iwahashi M, Nakamori M, Nakamura M, Ojima T, Naka T, Yamaue H. Optimal period for the prophylactic administration of neutrophil elastase inhibitor for patients with esophageal cancer undergoing esophagectomy. World J Surg. 2011;35:1573-9.
25. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-13. (Pubitemid 38963009)
26. Seely AJ, Ivanovic J, Threader J, Al-Hussaini A, Al-Shehab D, Ramsay T, et al. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg. 2010;90:936-42.
27. von Knorring J, Lepäntalo M, Lindgren L, Lindfors O. Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer. Ann Thorac Surg. 1992;53:642-7.
28. Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79:1698-703. (Pubitemid 40626717)
29. Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, et al. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation. 2007;115:1339-44. (Pubitemid 46648369)
30. Stippel DL, Taylan C, Schröder W, Beckurts KT, Hölscher AH. Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. Dis Esophagus. 2005;18:267-73. (Pubitemid 43904797)
31. Davis PA, Law S, Wong J. Colonic interposition after esophagectomy for cancer. Arch Surg. 2003;138:303-8. (Pubitemid 36292665)
32. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 2001;38:1231-66.
33. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 1996;335:1713-20. (Pubitemid 26399345)